Immunosuppressive therapy: guidelines for drug dosage. Depression of bone marrow granulocyte reserves in systemic lupus erythematosus.
D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000008:administration & dosage*; D001853:Bone Marrow / Q000187:drug effects*; D001856:Bone Marrow Examination; D005043:Etiocholanolone / Q000097:blood*; D005260:Female; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007165:Immunosuppression Therapy; D007958:Leukocyte Count; D007970:Leukopenia / Q000139:chemically induced*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage*
D005043:Etiocholanolone; D001379:Azathioprine; D011241:Prednisone